
Sign up to save your podcasts
Or
In today’s episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India’s decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.
4.9
3434 ratings
In today’s episode on 21st July 2025, we follow a $2 billion cancer-drug deal, review India’s decades-old drug-manufacturing playbook, and ask whether an “America-first” clampdown could force domestic drugmakers to climb the value ladder faster than ever.
39 Listeners
927 Listeners
11 Listeners
59 Listeners
60 Listeners
87 Listeners
40 Listeners
26 Listeners
6 Listeners
13 Listeners
15 Listeners
94 Listeners
9 Listeners
8 Listeners
15 Listeners